Intravenous Busulfan Compared with Total Body Irradiation Pretransplant Conditioning for Adults with Acute Lymphoblastic Leukemia
Partow Kebriaei(The University of Texas MD Anderson Cancer Center), Kirk R. Schultz(University of British Columbia), Matthew D. Seftel(CancerCare Manitoba), Michael A. Pulsipher(Primary Children's Hospital), Matthew J. Wieduwilt(Atrium Health Wake Forest Baptist), Christopher Bredeson, Ashish Bajel(The Royal Melbourne Hospital), Edward A. Copelan(Levine Cancer Institute), Gerhard Hildebrandt(University of Missouri Health System), Navneet S. Majhail(Sarah Cannon), Vinod Pullarkat(City of Hope), Ian Nivison‐Smith, Ann A. Jakubowski(Memorial Sloan Kettering Cancer Center), Marcos de Lima(The Ohio State University), Stephen J. Forman(City Of Hope National Medical Center), Ibrahim Aldoss(City of Hope), Zachariah DeFilipp(Harvard University), Hillard M. Lazarus(University Hospitals of Cleveland), César O. Freytes(CHRISTUS Transplant Institute), Ann E. Woolfrey(University of Washington), Jean‐Yves Cahn, Richard E. Champlin(The University of Texas MD Anderson Cancer Center), H. Jean Khoury(Emory University), Andrew Artz, Claudio Anasetti(Moffitt Cancer Center), David A. Rizzieri(Duke University), Nelli Bejanyan(Moffitt Cancer Center), Mark Hertzberg(The University of Sydney), Ulrike Bacher(Hattiesburg Clinic), Daniel J. Weisdorf(University of Minnesota), Celalettin Üstün(Rush University Medical Center), Minoo Battiwalla(Sarah Cannon), Joseph Alvarnas(City of Hope), William J. Hogan(Mayo Clinic), Brenda M. Sandmaier(University of Washington), Mark R. Litzow(Mayo Clinic in Arizona), Agnes S. M. Yong(South Australia Pathology), Robert Peter Gale(Imperial College London), Bipin N. Savani(Vanderbilt University Medical Center), Stefan O. Ciurea(University of California, Irvine), Mary M. Horowitz(Medical College of Wisconsin), Miguel Ángel Díaz(Hospital Infantil Universitario Niño Jesús), Geoffrey L. Uy(Memorial Sloan Kettering Cancer Center), Mei‐Jie Zhang(Second Affiliated Hospital of Zhejiang University), Hailin Wang(Fujian Normal University), Sid Ganguly(The University of Kansas Health System), David I. Marks(University Hospitals Bristol NHS Foundation Trust), Jean A. Yared(University of Maryland, Baltimore), Yoshi Inamoto, Jaap Jan Boelens(Wilhelmina Children's Hospital)
Cited by 98
Related Papers
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
|New England Journal of Medicine|2018|5.7k
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report
|Biology of Blood and Marrow Transplantation|2014|5.4k
Prognostic Relevance of Integrated Genetic Profiling in Acute Myeloid Leukemia
|New England Journal of Medicine|2012|1.9k
HLA-Haploidentical Bone Marrow Transplantation for Hematologic Malignancies Using Nonmyeloablative Conditioning and High-Dose, Posttransplantation Cyclophosphamide
|Biology of Blood and Marrow Transplantation|2008|1.9k
Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy
|New England Journal of Medicine|2016|1.8k